Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recombinant DNA technology and its diagnostic applications.

M J Arends1, C C Bird

  • 1Department of Pathology, University Medical School, Edinburgh, Scotland, UK.

Histopathology
|October 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The molecular cartography of malignant and benign sebaceous tumours.

Nature communications·2025
Same author

Genetic determinants of micronucleus formation in vivo.

Nature·2024
Same author

Rapid artefact removal and H&E-stained tissue segmentation.

Scientific reports·2024
Same author

Multiple-instance-learning-based detection of coeliac disease in histological whole-slide images.

Journal of pathology informatics·2023
Same author

The Haemostatic Mechanism and Menstruation: The Role of Intra-Uterine Contraceptive Devices.

Thrombosis and haemostasis·2019
Same author

Yorkshire Case Control Study of Leukaemias and Lymphomas Parallel Multivariate Analyses of Seven Disease Categories.

Leukemia & lymphoma·2016

Recombinant DNA technology offers specific diagnostic insights in pathology for genetic diseases and microorganism identification. Its application in tumor pathology aids in diagnosing leukemias and lymphomas, with potential for future solid tumor markers.

Area of Science:

  • Pathology
  • Molecular Biology
  • Genetics

Background:

  • Recombinant DNA technology has limited widespread diagnostic use in pathology.
  • Specific applications exist in genetic diseases, microbiology, and hematologic malignancies.

Purpose of the Study:

  • To outline the current and potential diagnostic applications of recombinant DNA technology in pathology.
  • To highlight its utility in genetic disease diagnosis, microbial identification, and tumor pathology.

Main Methods:

  • Analysis of diagnostic information from genetic diseases.
  • Sensitive and specific identification of microorganisms in tissue samples.
  • Genomic analysis for etiological, epidemiological, and pathogenetic insights.
  • Application in resolving diagnostic challenges in leukemia and lymphoma.

Related Experiment Videos

  • Detection of specific chromosomal translocations in tumor pathology.

    • Main Results:

    • Precise diagnostic information for genetic diseases, aiding counseling and research.
    • Enhanced sensitivity and specificity in identifying microorganisms and analyzing their genomes.
    • Successful resolution of diagnostic problems in leukemias and lymphomas through detection of chromosomal translocations.
    • Insights into tumorigenesis, with potential for future solid tumor markers.

    Conclusions:

    • Recombinant DNA technology is valuable in specific pathological diagnostic areas.
    • It enhances genetic disease diagnosis, microbial identification, and hematologic malignancy diagnostics.
    • Future applications may include prognostic and therapeutic markers for solid tumors.